Local Adverse Reaction Rates Decreased over Time during Treatment with Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Immunoglobulin G (IGHy) in Patients with Primary Immunodeficiency Disorders in the IGHy Phase 3 Studies

详细信息    查看全文

• 作者：Mark R. Stein ; MD ; FAAAAI¹ ; Richard L. Wasserman ; MD ; PhD ; FAAAAI² ; Isaac Melamed ; MD³ ; Sudhir Gupta ; MD ; PhD ; FAAAAI⁴ ; Lisa J. Kobrynski ; MD ; MPH ; FAAAAI⁵ ; Arye Rubinstein ; MD ; FAAAAI⁶ ; Christopher J. Rabbat ; PhD⁷ ; Werner Engl ; PhD⁸ ; Barbara McCoy ; PhD⁸ ; Heinz Leibl ; PhD⁸ ; Leman Yel ; MD ; FAAAAI⁹
• 刊名：Journal of Allergy and Clinical Immunology
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：137
• 期：2_supp_S
• 页码：AB220
• 全文大小：124 K

文摘